跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CLINIMIX - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CLINIMIX
Authorized
STANDARD
CLINIMIX
baxter corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
546bf0f53a58e835
Company
baxter corporation
Type
Standard
Approval Details
Approval Id
546bf0f53a58e835
Drug Approval Canada Name
CLINIMIX
Product Name
CLINIMIX
Status
Marketed
Status Date
2022-04-01
Original Market Date
2022-04-01
Din
02498448
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Ethical
Ahfs
40:20.00
Atc Original
B05BA10 COMBINATIONS
Atc Name
b 05 ba 10
Aig Number
1662220001
Company Name
baxter corporation
Company Address
7125 Mississauga Road, Mississauga, Ontario, Canada, L5N 0C2
Active Ingredients
ALANINE
1242 MG / 100 ML
DEXTROSE
5 G / 100 ML
HISTIDINE
288 MG / 100 ML
GLYCINE
618 MG / 100 ML
L-ISOLEUCINE
360 MG / 100 ML
L-ARGININE
690 MG / 100 ML
L-THREONINE
252 MG / 100 ML
L-VALINE
348 MG / 100 ML
L-LEUCINE
438 MG / 100 ML
L-LYSINE HYDROCHLORIDE
348 MG / 100 ML
L-PROLINE
408 MG / 100 ML
L-TYROSINE
24 MG / 100 ML
L-PHENYLALANINE
336 MG / 100 ML
METHIONINE
240 MG / 100 ML
SERINE
300 MG / 100 ML
TRYPTOPHAN
108 MG / 100 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
546bf0f53a58e835
Type
Standard
Back to Health Canada Approvals